Literature DB >> 28251129

Anti-mitochondrial autoantibodies-milestone or byway to primary biliary cholangitis?

Atsushi Tanaka1.   

Abstract

Entities:  

Year:  2017        PMID： 28251129      PMCID： PMC5326641          DOI： 10.21037/atm.2017.01.42

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Gastroenterology       Date:  2015-09-15       Impact factor: 22.682

2.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

Authors: 
Journal:  J Hepatol       Date:  2009-06-06       Impact factor: 25.083

3.  Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan.

Authors: 
Journal:  Hepatol Res       Date:  2014-01       Impact factor: 4.288

4.  Primary biliary cirrhosis.

Authors:  Keith D Lindor; M Eric Gershwin; Raoul Poupon; Marshall Kaplan; Nora V Bergasa; E Jenny Heathcote
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

5.  Antimitochondrial antibodies in patients with chronic hepatitis C.

Authors:  S Grimbert; C Johanet; F Bendjaballah; J C Homberg; R Poupon; M Beaugrand
Journal:  Liver       Date:  1996-06

6.  Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.

Authors:  Ana Lleo; Christopher L Bowlus; Guo-Xiang Yang; Pietro Invernizzi; Mauro Podda; Judy Van de Water; Aftab A Ansari; Ross L Coppel; Howard J Worman; Gregory J Gores; M Eric Gershwin
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

7.  Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.

Authors:  H Miyakawa; A Tanaka; K Kikuchi; M Matsushita; E Kitazawa; N Kawaguchi; H Fujikawa; M E Gershwin
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

8.  Apotopes and the biliary specificity of primary biliary cirrhosis.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Ross L Coppel; Ian R Mackay; Gregory J Gores; Aftab A Ansari; Judy Van de Water; M Eric Gershwin
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 9.  Primary biliary cirrhosis.

Authors:  Elizabeth J Carey; Ahmad H Ali; Keith D Lindor
Journal:  Lancet       Date:  2015-09-11       Impact factor: 79.321

10.  Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.

Authors:  Géraldine Dahlqvist; Farid Gaouar; Fabrice Carrat; Sofia Meurisse; Olivier Chazouillères; Raoul Poupon; Catherine Johanet; Christophe Corpechot
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425
View more
  1 in total

1.  PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis.

Authors:  Mahima T Rasquinha; Ninaad Lasrado; Erika Petro-Turnquist; Eric Weaver; Thiagarajan Venkataraman; Daniel Anderson; Uri Laserson; H Benjamin Larman; Jay Reddy
Journal:  Biology (Basel)       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.